Argonautica Private Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,416
Closed -$827K – 195
2026
Q1
$827K Buy
5,416
+545
+11% +$83.5K 0.25% 80
2025
Q4
$672K Buy
4,871
+776
+19% +$102K 0.2% 98
2025
Q3
$525K Buy
4,095
+126
+3% +$15.4K 0.15% 115
2025
Q2
$480K Sell
3,969
-80
-2% -$9.02K 0.15% 122
2025
Q1
$451K Buy
4,049
+453
+13% +$48.2K 0.16% 121
2024
Q4
$350K Buy
3,596
+277
+8% +$29.5K 0.11% 148
2024
Q3
$382K Buy
3,319
+14
+0.4% +$1.59K 0.13% 134
2024
Q2
$352K Buy
3,305
+4
+0.1% +$402 0.12% 140
2024
Q1
$319K Sell
3,301
-354
-10% -$36.3K 0.11% 154
2023
Q4
$369K Buy
3,655
+79
+2% +$7.63K 0.15% 133
2023
Q3
$364K Buy
3,576
+30
+0.8% +$3.04K 0.16% 122
2023
Q2
$358K Buy
3,546
+737
+26% +$73.7K 0.16% 117
2023
Q1
$258K Sell
2,809
-405
-13% -$35.4K 0.13% 123
2022
Q4
$292K Buy
+3,214
New +$271K 0.15% 119

Other funds holding NVS

Argonautica Private Wealth Management's NVS Position: Q2 2026 in Review

Argonautica Private Wealth Management sold out of Novartis (NVS) in Q2 2026, closing a stake of 5,416 shares — an estimated $827K sold.

Argonautica Private Wealth Management first reported a position in NVS in Q4 2022 and held it in 14 quarters. The position peaked at $827K in Q1 2026. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Argonautica Private Wealth Management reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Argonautica Private Wealth Management sold 5,416 Novartis shares in Q2 2026, an estimated $827K.
  • Argonautica Private Wealth Management first reported a position in Novartis in Q4 2022 and held it in 14 quarters.
  • Argonautica Private Wealth Management's Novartis position peaked at $827K in Q1 2026.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.